In an article posted on Health.com, Ephraim Tsalik helps describe the differences between pneumonia and bronchitis.
The Roundtable on Genomics and Precision Health at the National Academies is pleased to announce the release of their proceedings from the workshop
Deadline: February 15, 2019
The IGNITE II Network is looking to provide evidence of the clinical utility of genomic medicine.
Duke invests in students’ health through new wearables initiative
Rachel Myers, Thomas Ortel, Alexander Waldrop, Sandeep Dave, Geoff Ginsburg and Deepak Voora collaborated on a poster for AHA.
Micah McClain received a 4-year Merit Award from the VA to explore the host genomic response to rickettsial infections in human patients and develop novel PCR-based tests that are capable of accurately diagnosing Spotted Fever Group rickettsii and Scrub typhus infections, which will allow for better therapeutic decision making.
Lori Orlando is the PI of an NIH sub-contract for a supplemental proposal to Vanderbilt University’s Electronic MEdical Records and GEnomics (eMERGE) project. The goal of the project is to incorporate MeTree into the electronic health record (EHR) systems at three US sites and the National Health Service in England.
Tim Veldman, Tom Burke, and Geoff Ginsburg, along with Department of Neurology's Danny Laskowitz, Shreyansh Shah and Saurabh Sinha were awarded a grant from the Department of Defense Congressionally Directed Medical Research Program.
Deepak Voora and Geoff Ginsburg were awarded an internal grant from the Translating Duke Health Initiative.
Ricardo Henao was awarded a Subcontract through Vigilant Medical.
Geoff Ginsburg was part of a team that investigated the US landscape of research programs in PGx implementation, reviewed current advances and clinical applications of PGx, summarized the obstacles that have hindered PGx implementation, and identified the critical knowledge gaps and possible studies needed to help to address them.
Ginsburg co-authored an overview of precision medicine and its vital stakeholders. Haga along with Duke undergraduate research assistant Ariel Kantor report on their analysis of the number and types of pharmacogenetic tests offered by clinical testing laboratories in the U.S.
Led by researchers from Harvard Medical School and Harvard Pilgrim Health Care Institute, the study reported variation between Medicare contractors and private insurers regarding coverage of testing for cancer treatment.
Several CAGPM staff and faculty co-authored a paper published in Genetics in Medicine on implementation, adoption, and utility of family health history risk assessment in diverse care settings.
Rachel Mills and several other genetic counselors have published examples of pharmacogenetic testing applications across a range of medical specialties.
Deepak Voora, Susanne Haga and others evaluated the impact of pharmacogenetic testing-informed statin treatment compared to usual care with respect to patient adherence and LDL response.
The CGSU provides the infrastructure and operational excellence to support translational research in genome and implementation sciences.
The laboratory brings together expertise in molecular microbiology with genome sciences to develop next-generation diagnostic tests.
We support biobanking activities including IRB, sample collection, processing, storage, bar-coded chain of custody and e-inventory management.